We are live on ! Find out more
SCM

Sterling Capital Management Portfolio holdings

AUM $5.9B
1-Year Est. Return 29.63%
This Fund
S&P 500
This Quarter Est. Return
+1.97%
1 Year Est. Return
+29.63%
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$7.3B
AUM Growth
-$438M
Cap. Flow
-$385M
Cap. Flow %
-5.28%
Top 10 Hldgs %
23.31%
Holding
3,320
New
46
Increased
2,165
Reduced
525
Closed
74

Top Sells

Rank Stock Value
1
NDAQ icon
Nasdaq
NDAQ
+$90.2M
2
AFL icon
Aflac
AFL
+$85.3M
3
HSY icon
Hershey
HSY
+$53.5M
4
JNJ icon
Johnson & Johnson
JNJ
+$48.8M
5
ABBV icon
AbbVie
ABBV
+$46.6M

Sector Composition

Rank Sector Weight
1 Technology 23.63%
2 Financials 18.4%
3 Healthcare 12.02%
4 Consumer Discretionary 8.91%
5 Industrials 8.48%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
EPAC icon
2676
Enerpac Tool Group
EPAC
$1.89B
$2.3K ﹤0.01%
56
ARWR icon
2677
Arrowhead Research
ARWR
$12.5B
$2.29K ﹤0.01%
122
EVTC icon
2678
Evertec
EVTC
$1.77B
$2.28K ﹤0.01%
66
ADCT icon
2679
ADC Therapeutics
ADCT
$144M
$2.25K ﹤0.01%
1,132
+1,000
+758% +$2.62K
VXX icon
2680
iPath Series B S&P 500 VIX Short-Term Futures ETN
VXX
$146M
$2.24K ﹤0.01%
49
ULBI icon
2681
Ultralife
ULBI
$116M
$2.24K ﹤0.01%
301
+272
+938% +$2.24K
ARCB icon
2682
ArcBest
ARCB
$3.07B
$2.24K ﹤0.01%
24
HURN icon
2683
Huron Consulting
HURN
$2.42B
$2.24K ﹤0.01%
18
POWL icon
2684
Powell Industries
POWL
$7.55B
$2.22K ﹤0.01%
30
-8,958
-100% -$801K
CDMO
2685
DELISTED
Avid Bioservices, Inc. Common Stock
CDMO
$2.21K ﹤0.01%
179
+108
+152% +$1.24K
HBIO icon
2686
Harvard Bioscience
HBIO
$28.8M
$2.19K ﹤0.01%
104
+93
+845% +$2.14K
IDYA icon
2687
IDEAYA Biosciences
IDYA
$3.54B
$2.19K ﹤0.01%
85
ARTV
2688
Artiva Biotherapeutics
ARTV
$549M
$2.18K ﹤0.01%
216
+185
+597% +$2.22K
NL icon
2689
NLI Holdings
NL
$308M
$2.18K ﹤0.01%
280
+253
+937% +$2K
COMP icon
2690
Compass
COMP
$9.52B
$2.16K ﹤0.01%
369
-22
-6% -$139
WRBY icon
2691
Warby Parker
WRBY
$3.26B
$2.15K ﹤0.01%
89
ELVN icon
2692
Enliven Therapeutics
ELVN
$4.35B
$2.14K ﹤0.01%
95
+55
+138% +$1.43K
AVPT icon
2693
AvePoint
AVPT
$2.75B
$2.13K ﹤0.01%
129
CNMD icon
2694
CONMED
CNMD
$1.48B
$2.12K ﹤0.01%
31
-1
-3% -$70
CTGO icon
2695
Contango Silver & Gold Inc
CTGO
$654M
$2.1K ﹤0.01%
210
+192
+1,067% +$3.26K
TARS icon
2696
Tarsus Pharmaceuticals
TARS
$2.97B
$2.1K ﹤0.01%
38
TLYS icon
2697
Tilly's
TLYS
$130M
$2.1K ﹤0.01%
495
+448
+953% +$1.83K
DC icon
2698
Dakota Gold
DC
$821M
$2.09K ﹤0.01%
951
+827
+667% +$1.87K
UPWK icon
2699
Upwork
UPWK
$1.21B
$2.08K ﹤0.01%
127
GOLF icon
2700
Acushnet Holdings
GOLF
$5.34B
$2.06K ﹤0.01%
29
-1
-3% -$68

Similar funds

Sterling Capital Management's Q4 2024 Portfolio in Review

As of Q4 2024, Sterling Capital Management held 3,320 positions worth $7.3B, down 5.7% from $7.74B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Sterling Capital Management withdrew a net $385M in Q4 2024, closing 74 positions and reducing 525 holdings. Its most notable exit was iShares Russell 1000 Growth ETF, an estimated $4.12M position sold in full.

By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 23% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Sterling Capital Management opened a new position in iShares Russell 1000 Value ETF worth $10.5M.

  • Sterling Capital Management's largest Q4 2024 buy was iShares Russell 1000 Value ETF: 56,923 shares worth $10.5M.
  • Sterling Capital Management added most to Everest Group in Q4 2024, an estimated $103M increase.
  • Sterling Capital Management's biggest Q4 2024 reduction was Nasdaq, cutting an estimated $90.2M.
  • Sterling Capital Management fully exited iShares Russell 1000 Growth ETF in Q4 2024, selling an estimated $4.12M.
  • Sterling Capital Management's ten largest holdings make up 23% of its $7.3B portfolio in Q4 2024.
  • Sterling Capital Management opened 46 new positions and closed 74 in Q4 2024.
  • Sterling Capital Management's portfolio value fell 5.7% quarter-over-quarter to $7.3B.

Based on Sterling Capital Management's 13F filing for Q4 2024, filed 13 Feb 2025.